Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study - Qu, Wei-Feng; Ding, Zhen-Bin; Qu, Xu-Dong; Tang, Zheng; Zhu, Gui-Qi; Fu, Xiu-Tao; Zhang, Zi-Han; Zhang, Xin; Huang, Ao; Tang, Min; Tian, Meng-Xin; Jiang, Xi-Fei; et al. (BJS open, 2022)
Keywords: Original